Placebo effect observed in double-blinded food challenges for dogs with atopic dermatitis
Study finds placebo effect complicates food allergy testing in dogs with skin condition
A randomized, double-blinded, placebo-controlled trial in 12 dogs with atopic dermatitis and adverse food reactions found 91.7% tested posit…
Most dogs with itchy skin reacted to food challenges, but half also reacted to a fake diet, showing the placebo effect makes allergy tests u…
Systematic review links PPARγ to atopic dermatitis pathogenesis and identifies it as a potential therapeutic target.
Review suggests a protein target may be linked to eczema and could lead to new treatments
A systematic review synthesizes mechanistic evidence linking peroxisome proliferator-activated receptor gamma (PPARγ) to atopic dermatitis p…
A protein called PPARγ could be a key target for new eczema treatments, as it helps restore skin barrier function and regulate immune respon…
Topical PDE4 inhibitors show efficacy in pediatric atopic dermatitis meta-analysis
Could a new cream help kids with eczema find relief faster?
A meta-analysis of 5 RCTs (n=1877) in pediatric mild-to-moderate atopic dermatitis found topical PDE4 inhibitors were associated with higher…
A new class of eczema creams linked to faster relief and better skin clearance in kids, with no increase in side effects compared to standar…
Review suggests chemokine inhibition as prospective therapeutic target for atopic dermatitis
Review suggests chemokine pathways may be promising targets for eczema treatment
A review of basic and clinical research in patients with AD and AD model mice found that chemokine ligand-receptor interactions regulate imm…
Blocking specific immune signals in eczema skin reduced inflammation in mice, suggesting a new treatment path as human trials progress.